Schedule 13G ownership disclosure

Tracon Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 89237H100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
798,481
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001105806-18-000005
Form type
SC 13G/A
Filer
LYTTON LAURENCE W
CIK
CIK 1105806
Filed
Feb 14, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub